Europe Colorectal Cancer Screening Market Share

Statistics for the 2023 & 2024 Europe Colorectal Cancer Screening market share, created by Mordor Intelligence™ Industry Reports. Europe Colorectal Cancer Screening share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Europe Colorectal Cancer Screening Industry

The Europe colorectal cancer screening market is competitive and consists of several significant players across the region. The key players are developing novel products to compete with the existing products, while others are acquiring and partnering with the other companies trending in the market to expand their presence. Some market players in the studied market are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Olympus Corporation, Stryker, and FUJIFILM Corporation.

Europe Colorectal Cancer Screening Market Leaders

  1. Abbott Laboratories

  2. Epigenomics Inc.

  3. Exact Sciences Corporation

  4. F. Hoffmann-La Roche AG

  5. Novigenix SA

*Disclaimer: Major Players sorted in no particular order

Europe Colorectal Cancer Screening Market  Concentration

Europe Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)